Craft
Galapagos

Galapagos

Revenue

€484.8 M

FY, 2021

Market Capitalization

€2.6 B

2022-11-21

Galapagos Summary

Company summary

Overview
Galapagos is a biotechnology company. It specializes in the development and commercialization of small molecule medicines. The Company is engaged in pre-clinical studies and discovery programs in inflammation, fibrosis and other indications. 
Type
Public
Status
Active
Founded
1999
HQ
Mechelen, BE | view all locations
Website
http://www.glpg.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key people

  • Piet Wigerinck

    Piet Wigerinck, Chief Scientific Officer

    • Mary Kerr, Non-Executive Independent Director

      • Bart Filius

        Bart Filius, Chief Operating Officer & Chief Financial Officer

        • Peter Guenter, Non-Executive Independent Director

          LocationsView all

          5 locations detected

          • Mechelen, Flanders HQ

            Belgium

          • Waltham, MA

            United States

            230 CityPoint, 230 3rd Ave

          • Romainville, IDF

            France

            102 Av. Gaston Roussel

          • Leiden, ZH

            Netherlands

            Zernikedreef 16

          • Basel, BS

            Switzerland

            Aeschengraben 20

          Galapagos Financials

          Summary financials

          Revenue (Q3, 2022)
          €136.2M
          Gross profit (Q3, 2022)
          €103.6M
          Net income (Q3, 2022)
          €21.6M
          Cash (Q3, 2022)
          €675.5M
          EBIT (Q3, 2022)
          (€37.5M)
          Enterprise value
          $1.9B

          Footer menu